Pharvaris is a late‑stage biopharmaceutical company developing novel oral bradykinin B2 receptor antagonists to address bradykinin‑mediated angioedema conditions, including hereditary angioedema (HAE). We are expanding our U.S. Medical Affairs team and are looking for a Medical Science